Darnisha Atrice Ruth, SLP - Speech-Language Pathologist in Baker, LA

Darnisha Atrice Ruth, SLP is a Speech-language Pathologist based in Baker, Louisiana. Darnisha Atrice Ruth is licensed to practice in Louisiana (license number 9160) and her current practice location is 4971 Groom Rd, Baker, Louisiana. She can be reached at her office (for appointments etc.) via phone at (225) 775-7051.

NPI number for Darnisha Atrice Ruth is 1033832860 and her current mailing address is 1326 Church St, Zachary, Louisiana. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1033832860.

Contact Information

Darnisha Atrice Ruth, SLP
4971 Groom Rd,
Baker, LA 70714-3145
(225) 775-7051
(225) 774-7244



Healthcare Provider's Profile

Full NameDarnisha Atrice Ruth
GenderFemale
SpecialitySpeech-language Pathologist
Location4971 Groom Rd, Baker, Louisiana
Accepts Medicare AssignmentsDoes not participate in Medicare Program. She may not accept medicare assignment.
  NPI Data:
  • NPI Number: 1033832860
  • Provider Enumeration Date: 09/26/2022
  • Last Update Date: 09/26/2022

Medical Identifiers

Medical identifiers for Darnisha Atrice Ruth such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1033832860NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
235Z00000XSpeech-language Pathologist 9160 (Louisiana)Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Darnisha Atrice Ruth is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Darnisha Atrice Ruth, SLP
1326 Church St,
Zachary, LA 70791-2743

Ph: (225) 654-8208
Darnisha Atrice Ruth, SLP
4971 Groom Rd,
Baker, LA 70714-3145

Ph: (225) 775-7051

News Archive

Silence Therapeutics' Atu027 RNAi drug prevents pulmonary metastasis formation

Silence Therapeutics plc announces positive research findings demonstrating the ability of the Company's lead RNA interference (RNAi) drug candidate, Atu027, to prevent the formation of pulmonary metastasis in various animal models of cancer metastasis. Researchers showed that Atu027 inhibited multiple key biological processes that enable and contribute to the dissemination and formation of pulmonary metastases in a murine breast cancer metastasis model.

Consumer groups still concerned as insurance rules are considered by HHS

The Wall Street Journal Health Blog: Consumer groups are already concerned that insurers might lobby HHS Secretary Kathleen Sebelius to weaken the medical-loss ratio rules suggested by the National Association of Insurance Commissioners last week. "Today, consumer representatives sent a letter to HHS Secretary Kathleen Sebelius to urge her not to tinker too much with what the NAIC came up with." The medical-loss ratio rules will determine "how much insurers pay out in health care compared with the total premiums they collect.

Four Los Angeles area hospitals report zero central line infections

Hospitals in Los Angeles vary dramatically in terms of how well their intensive care units (ICUs) prevent central-line bloodstream infections, a cause of death, disability, and expense in our nations' hospitals that is largely preventable. On February 2, www.ConsumerReportsHealth.org will post hospital infection rates for 41 Los Angeles area hospitals, along with other critical patient safety and satisfaction information for consumers.

VeriStrat analysis shows patients with advanced NSCLC benefit from dual targeted therapies

Results from the VeriStrat analysis of a phase II trial of first line erlotinib in combination with sorafenib in patients with advanced non-small cell lung cancer were presented today at the 22nd EORTC-NCI-AACR Symposium on Molecular Targets in Cancer Therapeutics being held in Berlin, Germany by Egbert Smit, MD, PhD of the VU Medical Center, Amsterdam, The Netherlands.

Read more News

› Verified 5 days ago


Speech-Language Pathologist in Baker, LA

Mrs. Michelle Winfrey Reado, M.ED., CCC-SLP
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 3802 Myrtle St, Baker, LA 70714
Phone: 225-775-2562    
Miss Brittney Dion Raby, M.S. CCC-SLP, L-SLP
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 7206 Juno Dr, Baker, LA 70714
Phone: 225-341-9141    
Iris G. King,
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 1725 Felton St, Baker, LA 70714
Phone: 225-610-9390    
Ms. Andrea Monique Branch, M.ED
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 12812 Driftwood Dr, Baker, LA 70714
Phone: 225-775-6535    Fax: 225-324-8709

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.